China Meheco Group Co (SHSE:600056) Total Stockholders Equity: ¥11,973 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600056 China Meheco Group Co Ltd SHSE:600056
66 GF Score
Price ¥8.88
GF Value ¥10.45
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is China Meheco Group Co Total Stockholders Equity?

China Meheco Group Co SHSE:600056 -1.00% 66 Total Stockholders Equity is ¥11,973 Mil as of Jun. 2026. GuruFocus rates SHSE:600056 with a GF Score™ of 66/100 and a GF Value™ of ¥10.45 (Modestly Undervalued). The stock has 6 warning signs investors should review.

China Meheco Group Co's Total Stockholders Equity for the quarter that ended in Jun. 2026 was ¥11,973 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. China Meheco Group Co's Book Value per Share for the quarter that ended in Jun. 2026 was ¥8.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. China Meheco Group Co's Debt-to-Equity for the quarter that ended in Jun. 2026 was 0.57.

China Meheco Group Co  (SHSE:600056) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

China Meheco Group Co's Book Value per Share for the quarter that ended in Jun. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(11973.368-0)/1495.880
=8.00

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

China Meheco Group Co's Debt-to-Equity for the quarter that ended in Jun. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(4875.966 + 1961.773) / 11973.368
=0.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Meheco Group Co Total Stockholders Equity Related Terms

China Meheco Group Co Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for China Meheco Group Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Meheco Group Co Total Stockholders Equity Chart

China Meheco Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10,258.00 10,814.46 11,560.55 12,028.84 11,835.95

China Meheco Group Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11,723.58 11,852.96 11,835.95 12,018.00 11,973.37
SHSE:600056
66GF Score
China Meheco Group Co Ltd SHSE:600056
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of ¥11,973 Mil mean?
China Meheco Group Co (SHSE:600056) has a Total Stockholders Equity of ¥11,973 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for China Meheco Group Co and its competitors.
Is China Meheco Group Co's Total Stockholders Equity too high?
China Meheco Group Co's current Total Stockholders Equity is ¥11,973 Mil. Overall, China Meheco Group Co has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does China Meheco Group Co's Total Stockholders Equity compare to MCK and COR?
China Meheco Group Co's Total Stockholders Equity of ¥11,973 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Distribution company?
A good Total Stockholders Equity depends on the Medical Distribution industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for China Meheco Group Co and its competitors. China Meheco Group Co's current Total Stockholders Equity is ¥11,973 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Meheco Group Co stock overvalued right now?
Based on GuruFocus' analysis, China Meheco Group Co (SHSE:600056) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥10.45, compared to a current price of ¥8.88 — trading 15% below its estimated fair value. The current Total Stockholders Equity is ¥11,973 Mil. China Meheco Group Co's overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For China Meheco Group Co (SHSE:600056), the current Total Stockholders Equity is ¥11,973 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Meheco Group Co (SHSE:600056) Overvalued in 2026?

Based on GuruFocus' analysis, China Meheco Group Co stock appears to be undervalued. The current stock price of ¥8.88 is trading 15% below its estimated GF Value™ of ¥10.45. GuruFocus considers China Meheco Group Co to be Modestly Undervalued.

Key valuation signals for SHSE:600056:

  • Total Stockholders Equity: ¥11,973 Mil
  • GF Value™: ¥10.45 vs. price of ¥8.88 (15% below fair value)
  • GF Score™: 66/100 with 6 warning signs

No single metric tells the full story. See the SHSE:600056 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

China Meheco Group Co Business Description

Address No. 1 Xiying Street, Floor 18-28, Block B, Building 1, General Times Center, District 1, Fengtai, Beijing, CHN, 100073
China Meheco Group Co Ltd is engaged in the distribution and trading of botanical medicines, medical instruments, and pharmaceuticals. It offers botanic medicines and herbal products, as well as exports of natural medicines, including herbs, spices, plant extracts, bee products, and Chinese traditional medicines. The company's business scope covers the whole industry chain, from research and development, cultivation and processing, manufacturing, distribution, and logistics to international trading, academic promotion, and technical service. The corporation provides trading services for customers in the pharmaceutical and chemical field, covering APIs, preparations, biologicals, blood products, and others.
66GF Score

Get the complete analysis for SHSE:600056

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥8.88
Price
¥10.45
GF Value